News
Boston Scientific (NYSE: BSX) announced today that NICE issued guidance supporting the use of pulsed field ablation (PFA) for treating AFib.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback